Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

N-terminal pro-atrial natriuretic peptide measurement in plasma suggests covalent modification

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{37af616c06ee4653911378aea624995a,
title = "N-terminal pro-atrial natriuretic peptide measurement in plasma suggests covalent modification",
abstract = "The N-terminal fragment of cardiac-derived pro-B-type natriuretic peptide is a glycosylated polypeptide. It is unknown whether N-terminal pro-atrial natriuretic peptide (proANP) fragments are also covalently modified. We therefore evaluated the clinical performance of 2 distinctly different proANP assays on clinical outcome.",
keywords = "Atrial Natriuretic Factor, Cardiovascular Diseases, Follow-Up Studies, Heart Failure, Humans, Immunoassay, Linear Models, Predictive Value of Tests, Prognosis, Protein Precursors, ROC Curve",
author = "Ingrid Hunter and Urban Alehagen and Ulf Dahlstr{\"o}m and Rehfeld, {Jens F} and Crimmins, {Dan L} and Goetze, {Jens P}",
year = "2011",
doi = "10.1373/clinchem.2011.166330",
language = "English",
volume = "57",
pages = "1327--30",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry, Inc",
number = "9",

}

RIS

TY - JOUR

T1 - N-terminal pro-atrial natriuretic peptide measurement in plasma suggests covalent modification

AU - Hunter, Ingrid

AU - Alehagen, Urban

AU - Dahlström, Ulf

AU - Rehfeld, Jens F

AU - Crimmins, Dan L

AU - Goetze, Jens P

PY - 2011

Y1 - 2011

N2 - The N-terminal fragment of cardiac-derived pro-B-type natriuretic peptide is a glycosylated polypeptide. It is unknown whether N-terminal pro-atrial natriuretic peptide (proANP) fragments are also covalently modified. We therefore evaluated the clinical performance of 2 distinctly different proANP assays on clinical outcome.

AB - The N-terminal fragment of cardiac-derived pro-B-type natriuretic peptide is a glycosylated polypeptide. It is unknown whether N-terminal pro-atrial natriuretic peptide (proANP) fragments are also covalently modified. We therefore evaluated the clinical performance of 2 distinctly different proANP assays on clinical outcome.

KW - Atrial Natriuretic Factor

KW - Cardiovascular Diseases

KW - Follow-Up Studies

KW - Heart Failure

KW - Humans

KW - Immunoassay

KW - Linear Models

KW - Predictive Value of Tests

KW - Prognosis

KW - Protein Precursors

KW - ROC Curve

U2 - 10.1373/clinchem.2011.166330

DO - 10.1373/clinchem.2011.166330

M3 - Journal article

VL - 57

SP - 1327

EP - 1330

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 9

ER -

ID: 33124811